Randrup Hansen, C.;                     Grimm, D.;                     Bauer, J.;                     Wehland, M.;                     Magnusson, N.E.    
        Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma. Int. J. Mol. Sci. 2017, 18, 461.
    https://doi.org/10.3390/ijms18020461
    AMA Style
    
                                Randrup Hansen C,                                 Grimm D,                                 Bauer J,                                 Wehland M,                                 Magnusson NE.        
                Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences. 2017; 18(2):461.
        https://doi.org/10.3390/ijms18020461
    
    Chicago/Turabian Style
    
                                Randrup Hansen, Caroline,                                 Daniela Grimm,                                 Johann Bauer,                                 Markus Wehland,                                 and Nils E. Magnusson.        
                2017. "Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma" International Journal of Molecular Sciences 18, no. 2: 461.
        https://doi.org/10.3390/ijms18020461
    
    APA Style
    
                                Randrup Hansen, C.,                                 Grimm, D.,                                 Bauer, J.,                                 Wehland, M.,                                 & Magnusson, N. E.        
        
        (2017). Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences, 18(2), 461.
        https://doi.org/10.3390/ijms18020461